We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Stay up to date on the topics that matter to you

Fang Tian, PhD profile page

Director of Biological Content

at ATCC

Fang Tian is director of biological content at ATCC, where she leads cell line and hybridoma oversight and product development. She has expertise in cell and molecular biology, with prior research roles at Massachusetts General Hospital and the Hillman Cancer Institute.

Got a Question for Fang Tian, PhD?

Get in touch using the contact form linked here and we'll get back to you shortly.

Published Content

Total: 1

Gloved hand holding a 96-well plate with purple floating cells in the background, used in cell line development.

Article

The New Technologies Accelerating Cell Line Development

This article explores how automation, AI and genetic tools are transforming cell line development, streamlining cloning, improving productivity and enabling faster biologic drug production.

Never miss a story

with the Breaking Science News daily newsletter